Followers | 568 |
Posts | 12936 |
Boards Moderated | 1 |
Alias Born | 11/12/2010 |
Monday, March 24, 2014 2:03:47 PM
1) I have shares and have purchased them all very recently, especially over the last week, .05 avg.
2) I don't really "invest" in any OTC stocks, they are for trading not really investing. If you invest in the OTC market you easily can get wiped out but that mostly comes from not doing thorough research. A lot of garbage on the OTC. That being said, URHG is not one of those stocks, there is real assets here, great balance sheet. Just bad timing with gold prices and other factors. The number one thing that makes OTC stocks a bad investment is dilution and with URHG there is almost none, the amount that does occur is very very acceptable.
3) I saw URHG based on the chart. This type of chart is where $$$ can be made.
4) Despite what I said above about the OTC market and despite the crappy performance of the stock, at these prices, it's hard to go wrong. This stock can easily run back up to book value( .13 ) or even greater without any news happening. My target range is .10-.15 . However, if there is some sort of positive news, like the reclamation bond posted then I will sell some of my shares but I will hold most of them on that type of news for higher prices. At that point, on that type of news, I will become an "investor" here. However, I easily see 100%+ from here without any news. I think the company is raising the money for the bond through the open market right now, which is why we see the depressed price. It could be done at any time, especially if you see some large volume days. I personally think their best best would be to hire some small/inexpensive promoters to get some attention here and finish raising the money that way.
TO ANYONE READING THIS, ALL OF THIS IS MY OPINION, DO NOT MAKE ANY BUY/SELL ACTIONS BASED ON WHAT I SAY, DO YOUR OWN DD. Good luck.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM